Global EditionASIA 中文双语Français
Shanghai Free Trade Zone 9 years on / Reform and Innovation

Shanghai FTZ contributes to new drug development | Updated: 2022-11-01
Share - WeChat

China (Shanghai) Pilot Free Trade Zone, which is also known as Shanghai FTZ, was established in 2013. After its establishment, the continuous implementation of a series of measures closely linked to international trade rules has benefited new drug development a great deal.

According to Tian Wenzhi, founder of ImmuneOnco, which is a biopharmaceutical enterprise, registration itself took more than a month in the past, but currently, with more efficiency brought by Shanghai FTZ, clearance time for medical materials has been reduced to a few hours.

Marketing Authorization Holder is a system introduced to lighten enterprises’ burdens. 

Before its introduction, clinical trials could only be done after a series of procedures including the production of the drug, the construction of a workshop that meets GMP standards and the inspections carried out by relevant departments. Currently, marketing authorization holders enjoy more autonomy. They can either produce drugs in their own workshops or outsource them, which has greatly enhanced the efficiency of the research and development of new drugs.

In the first half of the year, the total revenue of Shanghai's biopharmaceutical industry reached 386.8 billion yuan ($53.12 billion), an increase of 0.4 percent year-on-year. By August, the output value reached 116.16 billion yuan, an increase of 3.9 percent year-on-year.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349